These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 30275760

  • 1. Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics.
    Shiu JS, Hsieh MJ, Chiou HL, Wang HL, Yeh CB, Yang SF, Chou YE.
    Int J Med Sci; 2018; 15(12):1334-1340. PubMed ID: 30275760
    [Abstract] [Full Text] [Related]

  • 2. A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
    Zhang W, Liu S, Liu K, Wang Y, Ji B, Zhang X, Liu Y.
    J Int Med Res; 2014 Jun; 42(3):611-8. PubMed ID: 24670536
    [Abstract] [Full Text] [Related]

  • 3. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S, Zhang W, Liu K, Ji B, Wang G.
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis.
    Cui L, Gao Y, Xie Y, Wang Y, Cai Y, Shao X, Ma X, Li Y, Ma G, Liu G, Cheng W, Liu Y, Liu T, Pan Q, Tao H, Liu Z, Zhao B, Shao Y, Li K.
    Crit Care; 2015 Mar 05; 19(1):73. PubMed ID: 25888255
    [Abstract] [Full Text] [Related]

  • 8. miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
    Liu Y, Zhang W, Liu S, Liu K, Ji B, Wang Y.
    Oncol Rep; 2017 Mar 05; 37(3):1857-1864. PubMed ID: 28184920
    [Abstract] [Full Text] [Related]

  • 9. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
    Zhang W, Liu S, Liu K, Ji B, Wang Y, Liu Y.
    Oncol Rep; 2014 Nov 05; 32(5):1913-22. PubMed ID: 25176394
    [Abstract] [Full Text] [Related]

  • 10. A Functional Polymorphism-Mediated Disruption of EGR1/ADAM10 Pathway Confers the Risk of Sepsis Progression.
    Chen F, Wang Y, Zhang W, Cai Y, Zhao T, Mai H, Tao S, Wei W, Li J, Chen X, Li X, Tang P, Fan W, Yang J, Ou M, Lu F, Lai Z, Chen H, Zou T, Sun F, Shao Y, Cui L.
    mBio; 2019 Aug 06; 10(4):. PubMed ID: 31387910
    [Abstract] [Full Text] [Related]

  • 11. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K, Takehara T, Tatsumi T, Miyagi T, Ishida H, Ohkawa K, Kanto T, Hiramatsu N, Hayashi N.
    Cancer Res; 2009 Oct 15; 69(20):8050-7. PubMed ID: 19826051
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
    Liu S, Zhang W, Liu K, Wang Y, Ji B, Liu Y.
    Oncol Rep; 2014 Dec 15; 32(6):2501-10. PubMed ID: 25242535
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of ADAM10 gene variants with sporadic Parkinson's disease in Chinese Han population.
    Zhou M, Lin Y, Lu L, Zhang Z, Guo W, Peng G, Zhang W, Zhu Z, Wu Z, Mo M, Yang X, Zhu X, Chen C, Chen X, Xu P.
    J Gene Med; 2021 Mar 15; 23(3):e3319. PubMed ID: 33527480
    [Abstract] [Full Text] [Related]

  • 16. An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population.
    Li Y, Liao F, Yin XJ, Cui LL, Ma GD, Nong XX, Zhou HH, Chen YF, Zhao B, Li KS.
    CNS Neurosci Ther; 2013 Oct 15; 19(10):785-94. PubMed ID: 23773531
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.